TY - JOUR
T1 - Evolving role of SPECT/CT in neuroendocrine tumors management staging, treatment response, and follow-up
AU - Fuccio, Chiara
AU - Spinapolice, Elena Giulia
AU - Chondrogiannis, Sotirios
AU - Maffione, Anna Margherita
AU - Trifiro, Giuseppe
AU - Colletti, Patrick M.
AU - Rubello, Domenico
PY - 2013/10
Y1 - 2013/10
N2 - The combined use of SPECT and CT strongly supports the molecular imaging of neuroendocrine tumors (NETs) with somatostatin receptor radiopharmaceuticals or with meta-iodobenzylguanidine. SPECT/CT fusion images provide potential attenuation correction, higher specificity, and accurate localization for the staging, evaluation of treatment response, and follow-up of NETs.
AB - The combined use of SPECT and CT strongly supports the molecular imaging of neuroendocrine tumors (NETs) with somatostatin receptor radiopharmaceuticals or with meta-iodobenzylguanidine. SPECT/CT fusion images provide potential attenuation correction, higher specificity, and accurate localization for the staging, evaluation of treatment response, and follow-up of NETs.
KW - MIBG scintigraphy
KW - Neuroendocrine tumor
KW - Somatostatin receptor scintigraphy
KW - SPECT/CT
UR - http://www.scopus.com/inward/record.url?scp=84897586547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897586547&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e3182952c6d
DO - 10.1097/RLU.0b013e3182952c6d
M3 - Article
C2 - 23751832
AN - SCOPUS:84897586547
VL - 38
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 10
ER -